Clinical Trial Update: Lidoderm Patch (Lidocaine 5%) for Tinnitus Treatment [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating the lidocaine 5% Lidoderm patch for the treatment of tinnitus. The current status is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tinnitus

Drugs mentioned

• Lidoderm Patch (lidocaine topical patch)

Snippet

Sponsor: HaEmek Medical Center, Israel | Conditions: Tinnitus | Phase 4 | Status: UNKNOWN